Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
About us

Publications

All →
WHO Drug Information - Volume 39, No. 3
3 October 2025

WHO Drug Information - Volume 39, No. 3

The Third issue of volume 39 for 2025 includes:Consultation Documents: Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum) Cefiderocol powder...

Download
Read More
Availability, price and affordability of health technologies for the management of diabetes
23 September 2025

Availability, price and affordability of health technologies for the management of diabetes

The WHO list of priority medical devices for management of cardiovascular diseases and diabetes, https://iris.who.int/handle/10665/341967, describes those...

Download
Read More
The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use
5 September 2025

The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification...

The AWaRe classification is intended as a tool for monitoring antibiotic use, defining targets and monitoring the impact of stewardship policies and interventions...

Download
Read More
The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines for Children, 10th list
5 September 2025

The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines for Children,...

Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...

Download
Read More